Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Tab 1

Research Article

Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis

Table 1

The demographic and baseline clinical parameters before treatment in 40 CL patients allocated to receive treatment with Shiunko and placebo.

ParametersPlacebo
()
Shiunko
()

Age [median (range), years]40.4 (18–53)38.1 (18–62)
Sex [number of males and females]12, 813, 7
Lesion sign
 Lesion size [median (range), mm2]91 (16–1,575)123 (13–1,578)
 Lesion location [ (%)]
  Face17 (85)15 (75)
  Neck2 (10)1 (5)
  Arm1 (5)3 (15)
  Eyelid0 (0)1 (5)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.